Advertisements


EyePoint Pharmaceuticals Faces A Big Opportunity

EyePoint Pharmaceuticals Faces A Big Opportunity.....»»

Category: topSource: seekingalphaDec 2nd, 2019

EyePoint Faces A Big Opportunity

EyePoint Faces A Big Opportunity.....»»

Category: topSource: seekingalphaDec 2nd, 2019

Is Verrica Pharmaceuticals Inc. (VRCA) A Good Stock To Buy?

Does Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) represent a good buying opportunity at the moment? Let’s quickly check the hedge fund inte.....»»

Category: topSource: insidermonkeyNov 28th, 2019

Apple Park construction included racial harassment, federal lawsuit charges

A contractor that worked on Apple’s $1.1 billion Apple Park headquarters in Cupertino faces a federal lawsuit over race-based harassment that allegedly took place while the building was under construction. The Equal Employment Opportunity Commi.....»»

Category: topSource: bizjournalsNov 19th, 2019

EyePoint Pharmaceuticals, Inc. (EYPT) CEO Nancy Lurker on Q3 2019 Results - Earnings Call Transcript

EyePoint Pharmaceuticals, Inc. (EYPT) CEO Nancy Lurker on Q3 2019 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaNov 7th, 2019

Allena Pharmaceuticals selloff today a buying opportunity, says Baird

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 7th, 2019

EyePoint Pharmaceuticals, Inc. 2019 Q3 - Results - Earnings Call Presentation

EyePoint Pharmaceuticals, Inc. 2019 Q3 - Results - Earnings Call Presentation.....»»

Category: topSource: seekingalphaNov 7th, 2019

Is Amneal Pharmaceuticals, Inc. (AMRX) Going To Burn These Hedge Funds ?

Does Amneal Pharmaceuticals, Inc. (NYSE:AMRX) represent a good buying opportunity at the moment? Let’s quickly check the hedge fund inte.....»»

Category: topSource: insidermonkeyOct 21st, 2019

Recent Dip Presents Buying Opportunity In Arena Pharmaceuticals

Recent Dip Presents Buying Opportunity In Arena Pharmaceuticals.....»»

Category: topSource: seekingalphaSep 26th, 2019

EyePoint Pharmaceuticals stock price target cut to $4.00 from $5.75 at B. Riley FBR

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchSep 24th, 2019

Aveo Pharmaceuticals CFO Matthew Dallas leaving to pursue new career opportunity

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 27th, 2019

Reata Pharmaceuticals 20% selloff brings buying opportunity, says Citi

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 16th, 2019

Bayer gets help from Trump as regulators reject warning that Roundup weedkiller causes cancer

The German pharmaceuticals giant faces thousands of Roundup lawsuits and has already lost three high-profile cases......»»

Category: topSource: moneycentralAug 12th, 2019

Mirum Pharma"s Lead Asset Has $450M Sales Opportunity, Raymond James Says In Bullish Initiation

Mirum Pharmaceuticals Inc (NASDAQ: MIRM) recently went public, offering 5 million sh.....»»

Category: blogSource: benzingaAug 12th, 2019

Hedge Funds Have Never Been This Bullish On Xenon Pharmaceuticals Inc (XENE)

Does Xenon Pharmaceuticals Inc (NASDAQ:XENE) represent a good buying opportunity at the moment? Let’s quickly check the hedge fund inte.....»»

Category: topSource: insidermonkeyJun 14th, 2019

Portola Pharmaceuticals: Headaches For Us, Buying Opportunity For Investors

Portola Pharmaceuticals: Headaches For Us, Buying Opportunity For Investors.....»»

Category: topSource: seekingalphaJun 6th, 2019

Eyepoint Pharmaceuticals (EYPT) Investor Presentation - Slideshow

Eyepoint Pharmaceuticals (EYPT) Investor Presentation - Slideshow.....»»

Category: topSource: seekingalphaJun 6th, 2019

Faces of the List: Amy Donohue of Bora Architects

For many reasons, it's a fine time to work for Portland's Bora Architects. For one, the firm continues to land a hefty amount of education design projects, one of the practice's staples during its 60 years. For another, the advent of opportunity z.....»»

Category: topSource: bizjournalsJun 5th, 2019

Aerpio Pharmaceuticals: Eye Spy An Opportunity

Aerpio Pharmaceuticals: Eye Spy An Opportunity.....»»

Category: topSource: seekingalphaMay 22nd, 2019

Marijuana Medicine: GW Pharmaceuticals Market Opportunity Could Double

This drugmaker's cannabidiol formulation could become more widely used following positive phase 3 trial results in tuberous sclerosis complex......»»

Category: topSource: foxnewsMay 7th, 2019

J&J profit boosted by better-than-expected pharma unit sales

Johnson & Johnson beat quarterly profit estimates on higher sales at its pharmaceuticals unit even as it faces fierce competition for some of its biggest drugs, sending the company's shares up more than 2 percent......»»

Category: topSource: reutersApr 16th, 2019